LikeMinds

LikeMinds is a biotechnology company focused on developing a dopamine-transporter imaging agent aimed at the detection and treatment of dopamine-related brain disorders. The company's platform offers early, accurate, and actionable diagnoses for conditions such as Parkinson's Syndrome and dementia. By enabling physicians to identify these diseases more effectively, LikeMinds seeks to improve treatment outcomes for patients suffering from dopamine-related brain disorders.